Ondansetron Solution For Injection 2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ondansetron: Solution for injection (2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Ondansetron 2mg/ml for Inj
Drug Image file default-drug-image.png
Ondansetron 40mg/20mL for Inj
Drug Image file default-drug-image.png
Ondansetron 4mg/2mL for Inj
Drug Image file default-drug-image.png
Ondansetron 2mg/ml for Inj
Drug Image file default-drug-image.png
Ondansetron 40mg/20mL for Inj

What is this Medicine?

ONDANSETRON (on DAN se tron) is used to treat nausea and vomiting caused by chemotherapy. It is also used to prevent or treat nausea and vomiting after surgery.

Similar Brand Name Drugs : Zofran: Solution for injection (2mg)
CVS Pharmacy Patient Statistics for Ondansetron: Solution for injection(2mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ondansetron Hydrochloride 2mg/ml Solution for Injection

NDC: 007037221
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Radiation-induced Nausea/vomiting Prophylaxis, Post-operative Nausea/vomiting (PONV) Prophylaxis, Chemotherapy-induced Nausea/vomiting Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Pruritus, Hyperemesis Gravidarum, Pregnancy-induced Nausea/vomiting, Post-operative Nausea/vomiting (PONV), Gastroenteritis, Cyclic Vomiting Syndrome

Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Protect from freezing
Avoid excessive heat (above 104 degrees F)
Ondansetron Hydrochloride 2mg/ml Solution for Injection

Reported Side Effects for Ondansetron Hydrochloride 2mg/ml Solution for Injection

Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Slow Heart Beat Incidence:
<6.0%*
Severity: SEVERE
Onset: RAPID
Nervousness Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
<6.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
2.0-8.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
2.0-5.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
2.0-16.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Retaining Urine Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
4.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
4.0-7.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
5.0%*
Severity: MODERATE
Onset: RAPID
Constipation Incidence:
6.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
8.0-20.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
9.0-13.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
9.0-13.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.0-27.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ondansetron

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.